Ambalal Sarabhai Enterprises Ltd

Ambalal Sarabhai Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ambalal Sarabhai Enterprises Ltd

₹ 38.0 -3.75%
25 Apr - close price
ase.life BSE: 500009
About

Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics[1]

Key Points

Business Overview:[1]
ASE is a pharmaceutical health care companies, which through its group companies, manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and abroad

Website BSE
  • Market Cap ₹ 291 Cr.
  • Current Price ₹ 38.0
  • High / Low ₹ 77.7 / 34.1
  • Stock P/E 22.8
  • Book Value ₹ 5.88
  • Dividend Yield 0.00 %
  • ROCE 5.96 %
  • ROE 6.60 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has delivered good profit growth of 21.7% CAGR over last 5 years
  • Debtor days have improved from 163 to 37.4 days.

Cons

  • Stock is trading at 6.45 times its book value
  • Promoter holding is low: 31.4%
  • Tax rate seems low
  • Company has a low return on equity of 10.1% over last 3 years.
  • Earnings include an other income of Rs.22.5 Cr.
  • Working capital days have increased from -1,100 days to 268 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
0.00 0.13 1.19 0.93 1.22 0.37 1.70 0.80 0.33 0.99 1.14 0.00 1.17
1.27 1.65 2.63 2.24 2.34 1.66 4.84 2.13 1.96 1.65 2.41 1.80 3.74
Operating Profit -1.27 -1.52 -1.44 -1.31 -1.12 -1.29 -3.14 -1.33 -1.63 -0.66 -1.27 -1.80 -2.57
OPM % -1,169.23% -121.01% -140.86% -91.80% -348.65% -184.71% -166.25% -493.94% -66.67% -111.40% -219.66%
1.18 -8.19 2.37 1.99 2.79 2.60 1.18 1.96 1.33 3.42 1.88 6.37 10.81
Interest 0.03 0.13 0.03 0.01 0.02 0.05 0.03 0.04 0.06 0.07 0.09 0.09 0.10
Depreciation 0.05 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02
Profit before tax -0.17 -9.89 0.86 0.63 1.62 1.23 -2.02 0.56 -0.39 2.66 0.49 4.45 8.12
Tax % 0.00% 5.36% 1.16% 17.46% 0.00% 8.94% 0.00% 0.00% 69.23% -76.32% 6.12% 3.15% -3.82%
-0.17 -10.42 0.86 0.52 1.62 1.12 -2.02 0.56 -0.65 4.70 0.46 4.31 8.43
EPS in Rs -0.02 -1.36 0.11 0.07 0.21 0.15 -0.26 0.07 -0.08 0.61 0.06 0.56 1.10
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
17 16 15 7 2 1 0 0 0 0 4 4 3
33 29 27 29 14 22 9 8 12 6 9 9 10
Operating Profit -17 -13 -12 -22 -13 -21 -9 -8 -12 -6 -5 -5 -6
OPM % -101% -85% -79% -310% -858% -2,265% -4,292% -139% -126% -191%
19 3 14 96 -1 24 6 25 3 9 10 8 22
Interest 7 9 8 2 3 1 1 0 1 0 0 2 0
Depreciation 12 2 3 15 2 0 0 0 0 0 0 0 0
Profit before tax -17 -21 -9 58 -19 2 -3 16 -9 3 4 1 16
Tax % 0% 0% 0% 21% 10% 166% 13% 2% -1% 14% 5% -217%
-17 -21 -9 46 -21 -1 -4 16 -9 3 4 3 18
EPS in Rs -2.25 -2.68 -1.19 5.96 -2.68 -0.19 -0.51 2.03 -1.23 0.39 0.54 0.34 2.33
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -13%
5 Years: %
3 Years: %
TTM: 3%
Compounded Profit Growth
10 Years: 8%
5 Years: 22%
3 Years: 44%
TTM: 4213%
Stock Price CAGR
10 Years: 23%
5 Years: 17%
3 Years: 2%
1 Year: -21%
Return on Equity
10 Years: -21%
5 Years: 13%
3 Years: 10%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 77 77 77 77 77 77 77 77 77 77 77 77 77
Reserves -44 -64 -73 -28 -46 -48 -52 -36 -46 -43 -39 -36 -32
22 27 30 30 22 11 11 11 11 10 11 10 8
88 97 103 65 64 91 103 73 58 40 30 31 29
Total Liabilities 143 137 136 144 116 131 139 125 100 83 80 81 81
48 46 43 21 16 15 15 14 14 13 13 13 12
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 58 56 56 83 76 56 56 56 27 26 26 25 25
37 34 37 40 24 60 68 54 60 44 41 43 44
Total Assets 143 137 136 144 116 131 139 125 100 83 80 81 81

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-1 1 -12 -69 -4 -13 -3 -5 -10 -8 2 -4
1 2 13 75 9 26 2 5 16 21 1 3
0 -4 -1 -3 -8 -12 -0 -0 -0 -16 -4 0
Net Cash Flow 0 -0 -0 3 -3 1 -1 -0 5 -3 -2 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 84 78 37 2 0 0 421 30 37
Inventory Days 54 6 76 23 48 57 0 2 0
Days Payable 390 391 321 729 3,974 13,253 1,612
Cash Conversion Cycle -252 -307 -207 -705 -3,927 -13,197 421 -1,580 37
Working Capital Days -1,059 -1,437 -1,635 -1,490 -10,757 -19,393 -3,650 83 268
ROCE % -18% -22% -34% -60% -13% -22% -7% 37% -4% 10% 11% 6%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
30.76% 30.76% 30.77% 30.77% 30.78% 30.78% 30.78% 30.78% 30.78% 31.35% 31.35% 31.35%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.38%
0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.10% 0.10%
69.24% 69.23% 69.23% 69.22% 69.22% 69.23% 69.21% 69.23% 69.22% 68.65% 68.54% 68.18%
No. of Shareholders 1,81,5891,80,1991,79,4041,78,2741,77,7431,75,2221,71,9441,70,0791,69,2281,72,3381,71,2211,70,912

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports